By Greg Freiherr, Editor, gfreiherr@cmp.comCopyeditors polish my work all the time. It's their job. I don't mind. Usually, they make me look pretty good. But as we were
By Greg Freiherr, Editor, gfreiherr@cmp.com
Copyeditors polish my work all the time. It's their job. I don't mind. Usually, they make me look pretty good. But as we were finishing the April 3 issue, I was worried.
Going over the news briefs, which we typically do at the very end, I came across one entitled, "Multislice finds new uses." It was 50 minutes to "drop dead," the hour when our printer must have the text if we are going to mail the issue on time; 50 minutes until we send the text to our Web master to go online April 1.
The "Multislice" brief was too long. I needed to cut four lines. It began, "Making the most of its merger juggernaut, GE Medical Systems added to its stable of multislice modalities . . ." Hold it! Cut "juggernaut"there goes one word.
I started over. "Making the most of its mergers, GE Medical Systems added to its stable of multislice modalities with the acquisition of Sunbeam." Whoa! Sunbeam? In multislice? I read on.
"The full line of toasters will enable both one-sided (1S) and two-sided (2S) applications. A light/dark algorithm allows for client preference."
1S? 2S? I looked at my wall clock, whose tickingusually imperceptiblenow sounded like a metronome. Forty-five minutes left.
"The company is hoping to complete its acquisition of Land O' Lakes in time to add contrast enhancement to both 1S and 2S models in increments of pat or stick. Patient compliance has been demonstrated to skyrocket with oral ingestion of the contrast substance. Increased demand for coronary artery imaging is expected to follow market saturation."
Hmmm. GEMS is headquartered in the dairy state, I thought. And its parent does make home appliances. Could its strategists be so diabolical, so ruthless as to plan the clogging of arteries coast to coast just to sell more CTs? Or was something else at work here? I called our production editor, who soon fell prey to my investigative skills and cracked like a Grade A egg. Admitting her conspiracy with copyediting, she blurted, "April Fools'!"
But I wondered: With all the big companies gone, and precious few small ones left, was this story really so far-fetched? April Fools' indeed.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.